Insider Transactions in Q4 2023 at Harpoon Therapeutics, Inc. (HARP)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
Jonathan G Drachman |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Nov 27
2023
|
Ronald Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+29.89%
|
-
|
|
Nov 27
2023
|
Scott Dunseth Myers |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+19.52%
|
-
|
|
Nov 27
2023
|
Andrew R Robbins |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Nov 27
2023
|
Lauren P Silvernail |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Nov 27
2023
|
Joseph S Bailes |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Nov 27
2023
|
Mark Chin |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+29.89%
|
-
|
|
Nov 26
2023
|
Julia Marie Eastland President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.31%
|
-
|
|
Nov 26
2023
|
Frank J Lanza Principal Fin. & Acctng Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+37.3%
|
-
|
|
Nov 26
2023
|
Luke Nathaniel Walker Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Oct 25
2023
|
New Leaf Biopharma Opportunities Ii, L.P. |
BUY
Open market or private purchase
|
Indirect |
171,500
+30.23%
|
-
|
|
Oct 25
2023
|
New Leaf Biopharma Opportunities Ii, L.P. |
BUY
Open market or private purchase
|
Direct |
1,372,000
+48.39%
|
-
|
|
Oct 25
2023
|
Ronald Hunt |
BUY
Open market or private purchase
|
Indirect |
1,543,500
+39.31%
|
-
|
|
Oct 01
2023
|
Ronald Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
3,035
+31.08%
|
-
|
|
Oct 01
2023
|
Scott Dunseth Myers |
BUY
Grant, award, or other acquisition
|
Direct |
5,797
+27.07%
|
-
|
|
Oct 01
2023
|
Mark Chin |
BUY
Grant, award, or other acquisition
|
Direct |
3,035
+31.08%
|
-
|